This is a Validated Antibody Database (VAD) review about mouse Ldb2, based on 1 published articles (read how Labome selects the articles), using Ldb2 antibody in all methods. It is aimed to help Labome visitors find the most suited Ldb2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ldb2 synonym: AI035351; AW146358; CLIM1; CLP-36; Ldb3; LIM domain-binding protein 2; LIM domain-binding factor CLIM1; carboxyl-terminal LIM domain-binding protein 1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (Q7)
  • western blot knockout validation; human; fig 2a
  • immunohistochemistry - paraffin section; human; fig 1c
Santa Cruz Biotechnology Ldb2 antibody (Santa Cruz, sc-101088) was used in western blot knockout validation on human samples (fig 2a) and in immunohistochemistry - paraffin section on human samples (fig 1c). Oncotarget (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (Q7)
  • western blot knockout validation; human; fig 2a
  • immunohistochemistry - paraffin section; human; fig 1c
Santa Cruz Biotechnology Ldb2 antibody (Santa Cruz, sc-101088) was used in western blot knockout validation on human samples (fig 2a) and in immunohistochemistry - paraffin section on human samples (fig 1c). Oncotarget (2017) ncbi
Articles Reviewed
  1. Yu H, Jia R, Zhao L, Song S, Gu J, Zhang H. LDB2 inhibits proliferation and migration in liver cancer cells by abrogating HEY1 expression. Oncotarget. 2017;8:94440-94449 pubmed publisher